Lindsay Morton
#87,715
Most Influential Person Now
American cancer epidemiologist
Lindsay Morton's AcademicInfluence.com Rankings
Lindsay Mortonmedical Degrees
Medical
#3574
World Rank
#4052
Historical Rank
#534
USA Rank
Epidemiology
#722
World Rank
#753
Historical Rank
#99
USA Rank
Download Badge
Medical
Lindsay Morton's Degrees
- Bachelors Biology University of California, Berkeley
- PhD Epidemiology Stanford University
Similar Degrees You Can Earn
Why Is Lindsay Morton Influential?
(Suggest an Edit or Addition)According to Wikipedia, Lindsay McOmber Morton is an American cancer epidemiologist who researches genetic susceptibility to second cancers. She is the acting chief of the radiation epidemiology branch and head of its cancer survivorship research unit at the National Cancer Institute.
Lindsay Morton's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. (2006) (1544)
- 2016 US lymphoid malignancy statistics by World Health Organization subtypes (2016) (722)
- Acute leukemia incidence and patient survival among children and adults in the United States, 2001-2007. (2012) (548)
- Reporting participation in epidemiologic studies: a survey of practice. (2006) (374)
- Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph). (2007) (366)
- Hepatitis C and non-Hodgkin lymphoma among 4784 cases and 6269 controls from the International Lymphoma Epidemiology Consortium. (2008) (313)
- Etiologic heterogeneity among non-Hodgkin lymphoma subtypes: the InterLymph Non-Hodgkin Lymphoma Subtypes Project. (2014) (280)
- Second solid cancers after radiation therapy: a systematic review of the epidemiologic studies of the radiation dose-response relationship. (2013) (233)
- Population‐based study of autoimmune conditions and the risk of specific lymphoid malignancies (2009) (231)
- Differences in incidence and trends of haematological malignancies in Japan and the United States (2013) (222)
- Cancer therapy shapes the fitness landscape of clonal hematopoiesis (2020) (218)
- InterLymph hierarchical classification of lymphoid neoplasms for epidemiologic research based on the WHO classification (2008): update and future directions. (2010) (210)
- Genome-wide Association Study Identifies Multiple Risk Loci for Chronic Lymphocytic Leukemia (2013) (190)
- Evolving risk of therapy-related acute myeloid leukemia following cancer chemotherapy among adults in the United States, 1975-2008. (2013) (185)
- Cigarette Smoking and Risk of Non-Hodgkin Lymphoma: A Pooled Analysis from the International Lymphoma Epidemiology Consortium (InterLymph) (2005) (181)
- Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32 (2010) (171)
- Trends in primary central nervous system lymphoma incidence and survival in the U.S. (2016) (168)
- Etiologic heterogeneity among non-Hodgkin lymphoma subtypes. (2008) (166)
- Second malignancy risks after non-Hodgkin's lymphoma and chronic lymphocytic leukemia: differences by lymphoma subtype. (2010) (166)
- Risk factors for early‐onset and late‐onset post‐transplant lymphoproliferative disorder in kidney recipients in the United States (2011) (156)
- Prior Medical Conditions and Medication use and Risk of non-Hodgkin lymphoma in Connecticut United States Women (2004) (152)
- Chimeric EWSR1-FLI1 regulates the Ewing sarcoma susceptibility gene EGR2 via a GGAA microsatellite (2015) (151)
- Proportions of Kaposi sarcoma, selected non-Hodgkin lymphomas, and cervical cancer in the United States occurring in persons with AIDS, 1980-2007. (2011) (149)
- Risk of non-Hodgkin lymphoma subtypes in HIV-infected people during the HAART era: a population-based study (2014) (140)
- Genome-wide association study identifies multiple susceptibility loci for diffuse large B-cell lymphoma (2014) (140)
- Incidence and patient survival of myeloproliferative neoplasms and myelodysplastic/myeloproliferative neoplasms in the United States, 2001–12 (2016) (139)
- Analysis of Heritability and Shared Heritability Based on Genome-Wide Association Studies for Thirteen Cancer Types. (2015) (133)
- Alcohol consumption and risk of non-Hodgkin lymphoma: a pooled analysis. (2005) (132)
- Medical history, lifestyle, family history, and occupational risk factors for peripheral T-cell lymphomas: the InterLymph Non-Hodgkin Lymphoma Subtypes Project. (2014) (131)
- The rising incidence of second cancers: patterns of occurrence and identification of risk factors for children and adults. (2014) (126)
- Autoimmune disease and subsequent risk of developing alimentary tract cancers among 4.5 million US male veterans (2011) (119)
- Incidence of marginal zone lymphoma in the United States, 2001–2009 with a focus on primary anatomic site (2014) (117)
- Prognostic significance of host immune gene polymorphisms in follicular lymphoma survival. (2007) (116)
- Consumption of Aspartame-Containing Beverages and Incidence of Hematopoietic and Brain Malignancies (2006) (115)
- GWAS of Follicular Lymphoma Reveals Allelic Heterogeneity at 6p21.32 and Suggests Shared Genetic Susceptibility with Diffuse Large B-cell Lymphoma (2011) (114)
- Common Gene Variants in the Tumor Necrosis Factor (TNF) and TNF Receptor Superfamilies and NF-kB Transcription Factors and Non-Hodgkin Lymphoma Risk (2009) (110)
- Reporting Participation in Epidemiologic Studies: A Survey of Practice (2006) (108)
- Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia (2016) (107)
- Alcohol, smoking, and body size in relation to incident Hodgkin's and non-Hodgkin's lymphoma risk. (2007) (107)
- Non‐Hodgkin lymphoma and obesity: A pooled analysis from the InterLymph Consortium (2007) (106)
- Risk of lymphoma subtypes after solid organ transplantation in the United States (2013) (103)
- Association of Chemotherapy for Solid Tumors With Development of Therapy-Related Myelodysplastic Syndrome or Acute Myeloid Leukemia in the Modern Era (2019) (103)
- Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in Patients With Osteosarcoma. (2020) (101)
- Genome-wide association study identifies five susceptibility loci for follicular lymphoma outside the HLA region. (2014) (101)
- Medical history, lifestyle, family history, and occupational risk factors for diffuse large B-cell lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes Project. (2014) (99)
- Cigarette smoking prior to first cancer and risk of second smoking-associated cancers among survivors of bladder, kidney, head and neck, and stage I lung cancers. (2014) (98)
- Changes in Cancer Registry Coding for Lymphoma Subtypes: Reliability Over Time and Relevance for Surveillance and Study (2006) (97)
- Personal use of hair dye and the risk of certain subtypes of non-Hodgkin lymphoma. (2008) (94)
- Stomach cancer risk after treatment for hodgkin lymphoma. (2013) (93)
- The Epidemic of Non–Hodgkin Lymphoma in the United States: Disentangling the Effect of HIV, 1992–2009 (2013) (93)
- Risk of subsequent malignant neoplasms in long-term hereditary retinoblastoma survivors after chemotherapy and radiotherapy. (2014) (90)
- Medical history, lifestyle, family history, and occupational risk factors for follicular lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes Project. (2014) (89)
- A pooled investigation of Toll-like receptor gene variants and risk of non-Hodgkin lymphoma. (2009) (89)
- Medical history, lifestyle, family history, and occupational risk factors for marginal zone lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes Project. (2014) (82)
- Risk, Risk Factors, and Surveillance of Subsequent Malignant Neoplasms in Survivors of Childhood Cancer: A Review. (2018) (79)
- Associations between anthropometry, cigarette smoking, alcohol consumption, and non-Hodgkin lymphoma in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. (2010) (79)
- Beyond maximum grade: modernising the assessment and reporting of adverse events in haematological malignancies. (2018) (78)
- Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia (2017) (77)
- A prospective investigation of serum 25‐hydroxyvitamin D and risk of lymphoid cancers (2009) (76)
- Human leukocyte antigen class I and II alleles in non-Hodgkin lymphoma etiology. (2010) (73)
- Host immune gene polymorphisms in combination with clinical and demographic factors predict late survival in diffuse large B-cell lymphoma patients in the pre-rituximab era. (2008) (71)
- Smoking, alcohol use, obesity, and overall survival from non‐Hodgkin lymphoma (2010) (66)
- Risk of Non–Hodgkin Lymphoma Associated with Germline Variation in Genes that Regulate the Cell Cycle, Apoptosis, and Lymphocyte Development (2009) (66)
- Immune mechanisms in non-Hodgkin lymphoma: joint effects of the TNF G308A and IL10 T3575A polymorphisms with non-Hodgkin lymphoma risk factors. (2007) (65)
- A Case–Control Study of Occupational Exposure to Trichloroethylene and Non-Hodgkin Lymphoma (2010) (59)
- Genome-Wide Association Study to Identify Susceptibility Loci That Modify Radiation-Related Risk for Breast Cancer After Childhood Cancer (2017) (58)
- Current knowledge and future research directions in treatment-related second primary malignancies (2014) (57)
- Rationale and Design of the International Lymphoma Epidemiology Consortium (InterLymph) Non-Hodgkin Lymphoma Subtypes Project. (2014) (57)
- Genetic variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2) and risk of non-Hodgkin lymphoma (2006) (57)
- Risk of treatment-related esophageal cancer among breast cancer survivors. (2012) (56)
- Hair dye use and risk of bladder cancer in the New England bladder cancer study (2011) (56)
- A genome-wide association study of marginal zone lymphoma shows association to the HLA region (2015) (55)
- Genetic variation in caspase genes and risk of non-Hodgkin lymphoma: a pooled analysis of 3 population-based case-control studies. (2009) (54)
- DRD2 genetic variation in relation to smoking and obesity in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (2006) (54)
- Radiation-related genomic profile of papillary thyroid carcinoma after the Chernobyl accident (2021) (54)
- Cigarette smoking and risk of non-Hodgkin lymphoma subtypes among women (2003) (54)
- Hepatitis C virus and risk of non-Hodgkin lymphoma: a population-based case-control study among Connecticut women. (2004) (53)
- Risk of myeloid neoplasms after solid organ transplantation (2014) (53)
- Associations of non-Hodgkin Lymphoma (NHL) risk with autoimmune conditions according to putative NHL loci. (2015) (51)
- National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Subsequent Neoplasms Working Group Report. (2017) (50)
- Leveraging epidemiology and clinical studies of cancer outcomes: recommendations and opportunities for translational research. (2013) (49)
- Risk of second cancers according to radiation therapy technique and modality in prostate cancer survivors. (2015) (48)
- Body mass index and risk of second obesity-associated cancers after colorectal cancer: a pooled analysis of prospective cohort studies. (2014) (48)
- Incidence of lymphoid neoplasms by subtype among six Asian ethnic groups in the United States, 1996–2004 (2008) (47)
- Genome-wide association study identifies multiple new loci associated with Ewing sarcoma susceptibility (2018) (46)
- Hepatitis C virus infection and risk of posttransplantation lymphoproliferative disorder among solid organ transplant recipients. (2007) (46)
- Alcohol use and risk of non-Hodgkin's lymphoma among Connecticut women (United States) (2003) (46)
- Organochlorine exposure, immune gene variation, and risk of non-Hodgkin lymphoma. (2009) (46)
- Prevalence of HIV Infection among U.S. Hodgkin Lymphoma Cases (2013) (46)
- Increased stomach cancer risk following radiotherapy for testicular cancer (2013) (46)
- Dietary flavonoid intake and non-Hodgkin lymphoma risk. (2008) (45)
- Medical history, lifestyle, family history, and occupational risk factors for mycosis fungoides and Sézary syndrome: the InterLymph Non-Hodgkin Lymphoma Subtypes Project. (2014) (44)
- Genetically predicted longer telomere length is associated with increased risk of B-cell lymphoma subtypes. (2016) (42)
- Reproductive factors, exogenous hormone use and risk of lymphoid neoplasms among women in the National Institutes of Health‐AARP Diet and Health Study Cohort (2009) (41)
- Increased Risk for Lymphoid and Myeloid Neoplasms in Elderly Solid-Organ Transplant Recipients (2010) (41)
- Contributions of Subtypes of Non-Hodgkin Lymphoma to Mortality Trends (2015) (41)
- Menstrual and reproductive factors and risk of non-Hodgkin's lymphoma among Connecticut women. (2004) (40)
- Hair dye use, genetic variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2), and risk of non-Hodgkin lymphoma. (2007) (39)
- Pancreatic cancer risk after treatment of Hodgkin lymphoma. (2014) (39)
- Genetic variation in Th1/Th2 pathway genes and risk of non‐Hodgkin lymphoma: a pooled analysis of three population‐based case‐control studies (2011) (38)
- Blood transfusion and risk of non-Hodgkin's lymphoma in Connecticut women. (2004) (37)
- Risk of diffuse large B‐cell lymphoma after solid organ transplantation in the United States (2014) (37)
- Lifestyle and Dietary Factors in Relation to Risk of Chronic Myeloid Leukemia in the NIH-AARP Diet and Health Study (2013) (36)
- A pooled analysis of three studies evaluating genetic variation in innate immunity genes and non‐Hodgkin lymphoma risk (2011) (35)
- Risk of esophageal cancer following radiotherapy for Hodgkin lymphoma (2014) (35)
- Medical history, lifestyle, family history, and occupational risk factors for sporadic Burkitt lymphoma/leukemia: the Interlymph Non-Hodgkin Lymphoma Subtypes Project. (2014) (34)
- Plasma Cell Neoplasms in US Solid Organ Transplant Recipients (2013) (34)
- Meat intake is not associated with risk of non-Hodgkin lymphoma in a large prospective cohort of U.S. men and women. (2012) (32)
- Subtype-specific incidence rates of lymphoid malignancies in Hong Kong compared to the United States, 2001-2010. (2016) (32)
- Medical history, lifestyle, family history, and occupational risk factors for lymphoplasmacytic lymphoma/Waldenström's macroglobulinemia: the InterLymph Non-Hodgkin Lymphoma Subtypes Project. (2014) (32)
- Residential proximity to industrial combustion facilities and risk of non-Hodgkin lymphoma: a case–control study (2013) (31)
- Census and geographic differences between respondents and nonrespondents in a case-control study of non-Hodgkin lymphoma. (2007) (31)
- PRRC2A and BCL2L11 gene variants influence risk of non-Hodgkin lymphoma: results from the InterLymph consortium. (2012) (31)
- Medical history, lifestyle, and occupational risk factors for hairy cell leukemia: the InterLymph Non-Hodgkin Lymphoma Subtypes Project. (2014) (31)
- Spatial-temporal analysis of non-Hodgkin lymphoma in the NCI-SEER NHL case-control study (2011) (30)
- HLA Class I and II Diversity Contributes to the Etiologic Heterogeneity of Non-Hodgkin Lymphoma Subtypes. (2018) (30)
- Hodgkin Lymphoma Among US Solid Organ Transplant Recipients (2010) (30)
- Polymorphisms in DNA Repair and One-Carbon Metabolism Genes and Overall Survival in Diffuse Large B-Cell Lymphoma (DLBCL) and Follicular Lymphoma (2008) (30)
- Increased pancreatic cancer risk following radiotherapy for testicular cancer (2016) (28)
- Smoking, variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2), and risk of non-Hodgkin lymphoma: a pooled analysis within the InterLymph consortium (2012) (28)
- Radiation dose and subsequent risk for stomach cancer in long-term survivors of cervical cancer. (2013) (28)
- Risk Factors for Melanoma Among Survivors of Non-Hodgkin Lymphoma. (2015) (27)
- Medical history, lifestyle, family history, and occupational risk factors for mantle cell lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes Project. (2014) (26)
- Second Primary Cancers After Intensity-Modulated vs 3-Dimensional Conformal Radiation Therapy for Prostate Cancer. (2016) (26)
- Risk of non-Hodgkin lymphoma after radiotherapy for solid cancers (2013) (25)
- Analysis of Heritability and Shared Heritability Based on Genome-Wide Association Studies for 13 Cancer Types (2015) (24)
- Association of Breast Cancer Risk After Childhood Cancer With Radiation Dose to the Breast and Anthracycline Use: A Report From the Childhood Cancer Survivor Study. (2019) (24)
- Molecular characteristics of diffuse large B-cell lymphoma in human immunodeficiency virus-infected and -uninfected patients in the pre-highly active antiretroviral therapy and pre-rituximab era (2014) (24)
- Variations in Chromosomes 9 and 6p21.3 with Risk of Non–Hodgkin Lymphoma (2010) (24)
- Genetic overlap between autoimmune diseases and non‐Hodgkin lymphoma subtypes (2019) (24)
- Burkitt lymphoma risk in U.S. solid organ transplant recipients (2013) (23)
- Mortality After Breast Cancer Among Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study. (2019) (23)
- Association of polygenic risk score with the risk of chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis. (2018) (23)
- Oncologic therapy shapes the fitness landscape of clonal hematopoiesis (2019) (22)
- Risk of Second Malignancies in Solid Organ Transplant Recipients Who Develop Keratinocyte Cancers. (2017) (21)
- Patterns of Cause-Specific Mortality Among 2053 Survivors of Retinoblastoma, 1914-2016. (2019) (21)
- Blood transfusion, anesthesia, surgery and risk of non‐Hodgkin lymphoma in a population‐based case–control study (2008) (21)
- Risk of subsequent myeloid neoplasms after radiotherapy treatment for a solid cancer among adults in the United States, 2000–2014 (2018) (21)
- Medical history, lifestyle, family history, and occupational risk factors for adult acute lymphocytic leukemia: the InterLymph Non-Hodgkin Lymphoma Subtypes Project. (2014) (20)
- Polymorphisms in DNA repair genes and risk of non‐Hodgkin lymphoma in a pooled analysis of three studies (2010) (20)
- Comprehensive Evaluation of Medical Conditions Associated with Risk of Non-Hodgkin Lymphoma using Medicare Claims (“MedWAS”) (2016) (20)
- Prevalence of pathogenic/likely pathogenic variants in the 24 cancer genes of the ACMG Secondary Findings v2.0 list in a large cancer cohort and ethnicity-matched controls (2018) (20)
- Lupus-related single nucleotide polymorphisms and risk of diffuse large B-cell lymphoma (2017) (19)
- Mating Habits of New Zealand Dusky Dolphins (2010) (18)
- Polycyclic aromatic hydrocarbons: determinants of residential carpet dust levels and risk of non-Hodgkin lymphoma (2015) (18)
- Radiotherapy for ductal carcinoma in situ and risk of second non-breast cancers (2017) (18)
- Recommendations for long-term follow-up of adults with heritable retinoblastoma. (2020) (18)
- HLA and Risk of Diffuse Large B cell Lymphoma After Solid Organ Transplantation (2016) (18)
- Genetic variation in catechol-O-methyltransferase (COMT) and obesity in the prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial (2007) (17)
- Cause-Specific Mortality Following Initial Chemotherapy in a Population-Based Cohort of Patients With Classical Hodgkin Lymphoma, 2000-2016. (2020) (17)
- Genetic variation in cell cycle and apoptosis related genes and multiple myeloma risk. (2009) (16)
- No Association between Radiation Dose from Pediatric CT Scans and Risk of Subsequent Hodgkin Lymphoma (2017) (16)
- Genetic variation in POT1 and risk of thyroid subsequent malignant neoplasm: A report from the Childhood Cancer Survivor Study (2020) (16)
- Risk of Rare Cancers Among Solid Organ Transplant Recipients (2020) (15)
- Risk of second primary papillary thyroid cancer among adult cancer survivors in the United States, 2000-2015. (2019) (15)
- Converting Epidemiologic Studies of Cancer Etiology to Survivorship Studies: Approaches and Challenges (2012) (15)
- Risk factors for non‐Hodgkin lymphoma subtypes defined by histology and t(14;18) in a population‐based case‐control study (2011) (14)
- Stomach Cancer Following Hodgkin Lymphoma, Testicular Cancer and Cervical Cancer: A Pooled Analysis of Three International Studies with a Focus on Radiation Effects (2017) (14)
- Human Leukocyte Antigen Class I and II Alleles and Overall Survival in Diffuse Large B-Cell Lymphoma and Follicular Lymphoma (2011) (14)
- A High-risk Haplotype for Premature Menopause in Childhood Cancer Survivors Exposed to Gonadotoxic Therapy (2018) (14)
- Bone and Soft‐Tissue Sarcoma Risk in Long‐Term Survivors of Hereditary Retinoblastoma Treated With Radiation (2019) (13)
- Risk of treatment-related esophageal cancer among breast cancer survivors. (2012) (13)
- Radiation dose to the esophagus from breast cancer radiation therapy, 1943-1996: an international population-based study of 414 patients. (2013) (13)
- Inherited genetic variation and overall survival following follicular lymphoma (2012) (13)
- Immunostaining to identify molecular subtypes of diffuse large B-cell lymphoma in a population-based epidemiologic study in the pre-rituximab era. (2011) (13)
- Successful use of whole genome amplified DNA from multiple source types for high-density Illumina SNP microarrays (2018) (13)
- Genetic variation in N-acetyltransferases 1 and 2, cigarette smoking, and risk of non-Hodgkin lymphoma (2009) (12)
- The Future of Childhood Cancer Survivorship: Challenges and Opportunities for Continued Progress. (2020) (12)
- Prediction of the location and size of the stomach using patient characteristics for retrospective radiation dose estimation following radiotherapy (2013) (12)
- Mutual Risks of Cutaneous Melanoma and Specific Lymphoid Neoplasms: Second Cancer Occurrence and Survival (2018) (12)
- Long-term risk of subsequent cancer incidence among hereditary and nonhereditary retinoblastoma survivors (2021) (12)
- Association Between Radioactive Iodine Treatment for Pediatric and Young Adulthood Differentiated Thyroid Cancer and Risk of Second Primary Malignancies (2022) (12)
- Risk of therapy-related myelodysplastic syndrome/acute myeloid leukemia after childhood cancer: a population-based study (2019) (11)
- A step toward slaying the hydra of second cancers (2011) (11)
- Two high-risk susceptibility loci at 6p25.3 and 14q32.13 for Waldenström macroglobulinemia (2018) (11)
- Genome-Wide Association Study in Irradiated Childhood Cancer Survivors Identifies HTR2A for Subsequent Basal Cell Carcinoma. (2019) (11)
- SLC6A3 and body mass index in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial (2009) (11)
- Subsequent Primary Neoplasms: Risks, Risk Factors, Surveillance, and Future Research. (2020) (11)
- Variation in Effects of Non-Hodgkin Lymphoma Risk Factors According to the Human Leukocyte Antigen (HLA)-DRB1*01:01 Allele and Ancestral Haplotype 8.1 (2011) (11)
- Pooling Prospective Studies to Investigate the Etiology of Second Cancers (2014) (10)
- Encouraging participation in medical research: what strategies work? (2008) (10)
- Investigation of spatio-temporal cancer clusters using residential histories in a case–control study of non-Hodgkin lymphoma in the United States (2015) (9)
- Dissecting lymphoma incidence to inform epidemiologic and clinical research (2013) (9)
- Non-Hodgkin Lymphoma, Body Mass Index, and Cytokine Polymorphisms: A Pooled Analysis from the InterLymph Consortium (2015) (9)
- Generalizability of “GWAS hits” in clinical populations: Lessons from childhood cancer survivors (2020) (9)
- Role of Germline Genetics in Identifying Survivors at Risk for Adverse Effects of Cancer Treatment. (2018) (9)
- Role of radiotherapy and chemotherapy in the risk of leukemia after childhood cancer: An international pooled analysis (2020) (9)
- Hepatitis B or C virus infection and risk of non-Hodgkin lymphoma among solid organ transplant recipients (2014) (8)
- 577: Quantifying Selection Bias in Epidemiologic Studies (2005) (8)
- Risk for malignancies of infectious etiology among adult survivors of specific non-Hodgkin lymphoma subtypes. (2019) (8)
- Immune-Related Adverse Events After Immune Checkpoint Inhibitors for Melanoma Among Older Adults (2022) (7)
- Subsequent Neoplasm Risk Associated With Rare Variants in DNA Damage Response and Clinical Radiation Sensitivity Syndrome Genes in the Childhood Cancer Survivor Study. (2020) (7)
- Low-frequency variation near common germline susceptibility loci are associated with risk of Ewing sarcoma (2020) (7)
- Cause‐specific mortality in individuals with lymphoplasmacytic lymphoma/Waldenström macroglobulinaemia, 2000–2016 (2020) (7)
- Contribution of Polygenic Risk to Hypertension Among Long-Term Survivors of Childhood Cancer (2021) (6)
- Association of Treatment for Hodgkin Lymphoma With Estrogen Receptor Status of Subsequent Breast Cancers (2018) (6)
- LIM domain only 2 protein expression, LMO2 germline genetic variation, and overall survival in diffuse large B-cell lymphoma in the pre-rituximab era (2012) (6)
- Breast Cancer After Childhood, Adolescent, and Young Adult Cancer: It's Not Just About Chest Radiation. (2017) (6)
- Benign Tumors in Long-Term Survivors of Retinoblastoma (2021) (6)
- Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in the Childhood Cancer Survivor Study. (2021) (6)
- Risk prediction of anthracycline-related cardiomyopathy (AC) in childhood cancer survivors (CCS): A COG-ALTE03N1 and CCSS report. (2019) (5)
- Antibiotic use and risk of non-Hodgkin's lymphoma: a population-based case–control study (2007) (5)
- Dose-volume effects of breast cancer radiation therapy on the risk of second oesophageal cancer. (2020) (5)
- Letter to the Editor: Risk factors for second acute myeloid leukemia/myelodysplastic syndrome among survivors of non-Hodgkin lymphoma (2015) (5)
- Smoking and lymphoma: a small part of a complex story (2012) (5)
- Telomere Length-Associated Genetic Variants and the Risk of Thyroid Cancer in Survivors of Childhood Cancer: A Report from the Childhood Cancer Survivor Study (CCSS) (2018) (5)
- National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: Consensus Recommendations for Subsequent Neoplasms (2017) (5)
- Clinical and genetic risk factors for radiation‐associated ototoxicity: A report from the Childhood Cancer Survivor Study and the St. Jude Lifetime Cohort (2020) (5)
- Epidemiology and Hereditary Aspects of Acute Leukemia (2013) (5)
- A NOVEL METHOD TO ESTIMATE LYMPHOCYTE DOSE AND APPLICATION TO PEDIATRIC AND YOUNG ADULT CT PATIENTS IN THE UNITED KINGDOM (2018) (5)
- Sex-related effect on immunotherapy response: implications and opportunities. (2019) (5)
- Cancer risk following lymphoid malignancies among HIV-infected people. (2020) (4)
- Evolving Strategies in Epidemiologic Research on Radiation and Cancer (2011) (4)
- Associations between non-Hodgkin lymphoma and renal cell carcinoma (2011) (4)
- Cause‐specific mortality following polycythemia vera, essential thrombocythemia, and primary myelofibrosis in the US population, 2001–2017 (2021) (4)
- Oncologic Therapy for Solid Tumors Alters the Risk of Clonal Hematopoiesis (2018) (4)
- Radiogenomic Predictors of Adverse Effects following Charged Particle Therapy. (2018) (4)
- Risk factors for the development of cutaneous melanoma after allogeneic hematopoietic cell transplantation. (2018) (4)
- Common Genetic Polymorphisms Contribute to the Association between Non-Melanoma Skin Cancer and Chronic Lymphocytic Leukemia (2017) (4)
- Risk of Second Primary Bone and Soft-Tissue Sarcomas Among Young Adulthood Cancer Survivors. (2019) (4)
- Genetically Determined Height and Risk of Non-hodgkin Lymphoma (2020) (4)
- Genetic variation in the body mass index of adult survivors of childhood acute lymphoblastic leukemia: A report from the Childhood Cancer Survivor Study and the St. Jude Lifetime Cohort (2020) (3)
- Re: No Increased Risk of non-Hodgkin's Lymphoma with Steroids, Estrogens and Psychotropics (Netherlands) (2004) (3)
- Polygenic Risk Score Improves Risk Stratification and Prediction of Subsequent Thyroid Cancer after Childhood Cancer (2021) (3)
- Household endotoxin levels and the risk of non-Hodgkin lymphoma (2012) (3)
- 333 SECOND CANCERS FOLLOWING RADIOTHERAPY IN PROSTATE CANCER PATIENTS IN THE PROSTATE, LUNG, COLORECTAL AND OVARIAN (PLCO) CANCER SCREENING TRIAL (2013) (3)
- Subsequent Cancers in Patients Affected with Moderate or Severe Chronic Graft-versus-Host Disease. (2021) (3)
- Comparison of Radiation Dose Reconstruction Methods to Investigate Late Adverse Effects of Radiotherapy for Childhood Cancer: A Report from the Childhood Cancer Survivor Study (2019) (3)
- Genome‐wide Association Studies Reveal Novel Locus With Sex‐/Therapy‐Specific Fracture Risk Effects in Childhood Cancer Survivors (2020) (3)
- Reaching beyond maximum grade: progress and future directions for modernising the assessment and reporting of adverse events in haematological malignancies. (2022) (3)
- Body mass index and survival of patients with lymphoma (2020) (3)
- Increased risk of skin cancer in 1851 long-term retinoblastoma survivors. (2021) (3)
- Triple jeopardy for Hodgkin lymphoma survivors? (2014) (3)
- Stomach Cancer Risk After Treatment for (2013) (3)
- Host Genetic Variation in the Cell Cycle and NF-κB Pathways and Overall Survival in Mantle Cell Lymphoma. (2007) (2)
- Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes (2022) (2)
- Lymphoma Epidemiology Consortium (InterLymph) research from the Pathology Working Group of the International Proposed classification of lymphoid neoplasms for epidemiologic (2011) (2)
- Testicular Cancer as a Model for Understanding the Impact of Evolving Treatment Strategies on the Long-Term Health of Cancer Survivors. (2020) (2)
- Abstract 2691: Genome-wide association study identifies two susceptibility loci that modify radiation-related risk for breast cancer after childhood cancer: A report from the Childhood Cancer Survivor Study and St. Jude Lifetime Cohort (2016) (2)
- Cancer risk following post‐transplant lymphoproliferative disorders in solid organ transplant recipients (2019) (2)
- Breast Cancer After Childhood, Adolescent, and Young Adult Cancer: It's Not Just About Chest Radiation. (2017) (2)
- Common genetic polymorphisms contribute to the association between chronic lymphocytic leukaemia and non-melanoma skin cancer. (2021) (2)
- Polymorphisms in One-Carbon Metabolism Genes and Overall Survival in Diffuse Large B-Cell Lymphoma (DLBCL). (2007) (2)
- Risk factors for melanoma among survivors of non-Hodgkin lymphoma in the U.S. elderly population. (2014) (2)
- Immune mechanisms in non-Hodgkin lymphoma: Joint effects of the tumor necrosis factor (TNF) G308A and interleukin 10 (IL10) T3575A polymorphisms with environmental exposures (2007) (1)
- Abstract LB-184: Risk factors for lung cancer among survivors of non-Hodgkin lymphoma (2015) (1)
- P-226: Determinants of PCB Concentrations in Household Carpet Dust (2012) (1)
- Incidence and Patient Survival of Myeloproliferative Neoplasms (MPNs) and Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPNs) in the United States: A Population-Based View of the Modern Diagnostic Era (2015) (1)
- The bidirectional increased risk of B-cell lymphoma and T-cell lymphoma. (2021) (1)
- Combined effect of radiotherapy and anthracyclines on risk of breast cancer among female childhood cancer survivors: A report from the Childhood Cancer Survivor Study (CCSS). (2019) (1)
- Emerging Risks of AML/MDS and Other Myeloid Neoplasms Following Chemotherapy for First Primary Malignancy, 2000-2012 (2015) (1)
- Using patient-reported outcomes to improve survivorship care. (2020) (1)
- Sex- and Subtype-Specific Analysis of H2AFX Polymorphisms in Non-Hodgkin Lymphoma (2013) (1)
- Risk of Acute Myeloid Leukemia Among Solid Organ Transplant Recipients (2011) (1)
- Abstract 1333: Specific RB1 mutations and risk of subsequent neoplasms among survivors of hereditary retinoblastoma. (2013) (1)
- Hepatitis C virus infection and risk of post-transplant lymphoproliferative disorder among solid organ transplant recipients (2007) (1)
- Subsequent neoplasm risk associated with rare variants in DNA repair and clinical radiation sensitivity syndrome genes: A report from the Childhood Cancer Survivor Study. (2019) (1)
- Inflated expectations: Rare-variant association analysis using public controls (2023) (1)
- A novel locus on 6p21.2 for cancer treatment-induced cardiac dysfunction among childhood cancer survivors. (2022) (1)
- Re: Hair dye use, genetic variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2), and risk of non-Hodgkin lymphoma, author response. (2008) (1)
- Original Article Immunostaining to identify molecular subtypes of diffuse large B-cell lymphoma in a population-based epidemi- ologic study in the pre-rituximab era (2011) (0)
- Incidence of myeloid malignancies by subtype in Hong Kong and comparisons with Asian and white men and women in the United States (2022) (0)
- Risk of subsequent breast cancer after radiotherapy according to hormone-receptor status: A nested case-control study in the Childhood Cancer Survivor Study (CCSS). (2017) (0)
- Household endotoxin levels and the risk of non-Hodgkin lymphoma (2013) (0)
- Patterns of Cutaneous Malignancy Risk Among Survivors of Non-Hodgkin Lymphoma Subtypes (2016) (0)
- Brief report PRRC2A and BCL2L11 gene variants influence risk of non-Hodgkin lymphoma: results from the InterLymph consortium (2012) (0)
- Cytokine Gene Polymorphisms and Overall Survival in Follicular Lymphoma: Results from a Large Population-Based Study. (2006) (0)
- Subsequent Solid Neoplasms Following Hematopoietic Cell Transplantation (HCT) for Hematologic Malignancies: Comparing Center for International Blood and Marrow Transplant Research (CIBMTR) and California Cancer Registry (CCR) Data (2022) (0)
- Risks of therapy-related hematologic neoplasms beyond myelodysplastic syndromes and acute myeloid leukemia. (2022) (0)
- Racial and ethnic differences in risk of second primary cancers among prostate cancer survivors (2020) (0)
- Abstract 5644: Second cancer risks among lymphoma survivors in the SEER-Medicare linked dataset (2010) (0)
- No Association between Radiation Dose from Pediatric CT Scans and Risk of Subsequent Hodgkin Lymphoma CancerEpidemiology,Biomarkers&Prevention (2017) (0)
- Alcohol Intake and Risk of Non-Hodgkin Lymphomas in the Prospective Nih-Aarp Diet and Health Study (2006) (0)
- Abstract 5206: Recent incidence trends of lymphoid malignancies in Hong Kong, 2001-2010 (2016) (0)
- Title: Genetic Architecture of Diabetes Mellitus in Long-term Survivors of Childhood Cancer Working Group: Genetics Chronic Disease Investigators: (2017) (0)
- Patterns of autoimmunity and subsequent solid tumors among 4.5 million U.S. veterans (2008) (0)
- Abstract 1025: Risk of diffuse large B-cell lymphoma in solid organ transplant recipients (2012) (0)
- Germline Single Nucleotide Polymorphisms (SNPs) in IL1A , IL6 , IL10 , and IFNGR2 in Combination with Clinical with Demographic Factors Predict Overall Survival in Diffuse Large B-Cell Lymphoma (DLBCL). (2006) (0)
- Genome-wide association study using whole-genome sequencing to identify a novel locus associated with cardiomyopathy risk in adult survivors of childhood cancer: Utility of a two-stage analytic approach. (2019) (0)
- Population-Based, Cause-Specific Risk of Non-Lymphoma Deaths Among 20,491 Adults with Classical Hodgkin Lymphoma (cHL) Treated with Initial Chemotherapy in the United States, 2000-2015 (2019) (0)
- Abstract 935: Genetic variants in chromosome 6p21.3 and risk of non-Hodgkin lymphoma (2010) (0)
- Abstract LB-304: Oncologic therapy for solid tumors alters the risk of clonal hematopoiesis (2019) (0)
- Risk for New Malignancies of Potential Infectious Etiology Among Adult Survivors of Specific Non-Hodgkin Lymphoma Subtypes (2016) (0)
- Genome-wide association study of meningioma as a subsequent neoplasm: A report from the Childhood Cancer Survivor Study (CCSS) and St. Jude Lifetime Cohort (SJLIFE). (2016) (0)
- Consumption of Aspartame-Containing Beverages and Incidence of Hematopoietic and Brain Malignancies (2007) (0)
- Polygenic risk of subsequent thyroid cancer after childhood cancer: A report from St. Jude lifetime cohort (SJLIFE) and Childhood Cancer Survivor Study (CCSS). (2019) (0)
- Successful use of whole genome amplified DNA from multiple source types for high-density Illumina SNP microarrays (2018) (0)
- Genome-Wide Association Study in Irradiated Childhood Cancer Survivors Identifies HTR2A for Subsequent Basal Cell Carcinoma (2019) (0)
- Assessment of surveillance versus etiologic factors in the reciprocal association between papillary thyroid cancer and breast cancer. (2021) (0)
- JAAD Risk factors for the development of cutaneous melanoma after allogeneic hematopoietic cell transplantation supplemental materials (2019) (0)
- Abstract 2966: A genome-wide scan identifies a new locus associated with pediatric rhabdomyosarcoma (2018) (0)
- Risk of Treatment-Related Stomach Cancer Among Hodgkin Lymphoma Survivors (2010) (0)
- non-Hodgkin lymphoma Organochlorine exposure, immune gene variation, and risk of (2013) (0)
- Abstract 3725: Subsequent gastrointestinal cancer risks of childhood and early adulthood cancer survivors (2015) (0)
- Host Immunogenetic Single Nucleotide Polymorphisms (SNPs) Predict Overall Survival in Small Lymphocytic Lymphoma. (2006) (0)
- Abstract 5207: Comparison of subtype-specific incidence rates of lymphoid malignancies in Hong Kong and the United States (2016) (0)
- Abstract 3122: A functionalPOT1variant and risk of thyroid subsequent malignant neoplasm: A report from the Childhood Cancer Survivor Study (2019) (0)
- HAGHL genetic variants increase first fracture risk (FFR) in female childhood cancer survivors: A report from the Childhood Cancer Survivor Study (CCSS) and St. Jude Lifetime Cohort Study (SJLIFE). (2020) (0)
- Abstract 600: Telomere length-associated genetic variants and the risk of thyroid cancer after childhood cancer: A report from the Childhood Cancer Survivor Study (CCSS) (2018) (0)
- Environmental and genetic risk factors for t(14;18) subtypes of diffuse large B-cell lymphoma in a population-based, case-control study (2007) (0)
- Trends in Malignant Brain and Central Nervous System Tumor Incidence by Subtype Among Children in the United States, 1998-2013 (2017) (0)
- Author response for "Genome-wide Association Studies Reveal Novel Locus With Sex-/Therapy-Specific Fracture Risk Effects in Childhood Cancer Survivors" (2020) (0)
- Two high-risk susceptibility loci at 6p25.3 and 14q32.13 for Waldenström macroglobulinemia (2018) (0)
- Aspartame Consumption and Incidence of Hematopoietic and Brain Cancers (2007) (0)
- Linking the Center for International Blood and Marrow Transplant Research (CIBMTR) Registry to the California Cancer Registry and California Hospital Patient Discharge Data. (2022) (0)
- Abstract 5703: Oncologic therapy shapes the fitness landscape of clonal hematopoiesis (2020) (0)
- Risk of subsequent malignant neoplasms in long-term retinoblastoma survivors following chemotherapy and radiotherapy. (2014) (0)
- Abstract LB-236: Risk of tMDS/AML after chemotherapy for first primary lymphoid malignancy, 2000-2013 (2017) (0)
- Abstract PO-055: Molecular characterization of papillary thyroid cancer in relation to ionizing radiation dose following the Chernobyl accident (2021) (0)
- Genome-Wide Association Study for Waldenström Macroglobulinemia Identifies Novel Susceptibility Loci (2017) (0)
- Comparison of Vital Status and Cause-Specific Mortality after Hematopoietic Cell Transplantation between the Center for International Blood and Marrow Transplant Research and the California Cancer Registry: A Record-Linkage Analysis from 1991 to 2018 (2022) (0)
- Joint effects of general population polygenic risk scores (PRS) and radiation treatment on subsequent neoplasm risk among childhood cancer survivors: A report from the Childhood Cancer Survivor Study (CCSS). (2022) (0)
- Second Tumors in Retinoblastoma Survivors (2015) (0)
- Abstract 2970: Multiple new susceptibility loci identified in genome-wide association study of Ewing sarcoma (2018) (0)
- A high-risk genetic profile for premature menopause (PM) in childhood cancer survivors (CCS) exposed to gonadotoxic therapy: A report from the St. Jude Lifetime Cohort (SJLIFE) and Childhood Cancer Survivor Study (CCSS). (2017) (0)
- Cause-specific mortality in individuals with lymphoplasmacytic (2020) (0)
- HOST GENETIC VARIATION IN THE TNF AND NF‐ĸB PATHWAYS AND PROGNOSIS IN MANTLE CELL LYMPHOMA: AN ANALYSIS OF 2 STUDIES (2017) (0)
- Smoking, Obesity and Overall Survival in Non-Hodgkin Lymphoma (NHL): A Population-Based Study. (2006) (0)
- Abstract 934: A pooled investigation of circulating adiponectin levels and risk of multiple myeloma (2015) (0)
- Novel Insights Into the Long-Term Immune Health of Diffuse Large B-Cell Lymphoma Survivors. (2020) (0)
- Targeted long-read sequencing of the Ewing sarcoma 6p25.1 susceptibility locus identifies germline-somatic interactions with EWSR1-FLI1 binding. (2023) (0)
- Practice of Epidemiology Census and Geographic Differences between Respondents and Nonrespondents in a Case-Control Study of Non-Hodgkin Lymphoma (2008) (0)
- Abstract 5501: The non-Hodgkin lymphoma epidemic in the United States: Recent trends in the absence of HIV-related cases (2012) (0)
- OP-JNCI190094 749..750 (2019) (0)
- Utilization of Autologous HCT in Multiple Myeloma: A Novel Linkage of CIBMTR, Cancer Registry and Hospitalization Data in California (2022) (0)
- Molecular characterization of gastric adenocarcinoma diagnosed in patients previously treated for Hodgkin lymphoma or testicular cancer (2022) (0)
- disorder among solid organ transplant recipients Hepatitis C virus infection and risk of post-transplant lymphoproliferative (2013) (0)
- Prevalence of pathogenic/likely pathogenic variants in the 24 cancer genes of the ACMG Secondary Findings v2.0 list in a large cancer cohort and ethnicity-matched controls (2018) (0)
- Genetic and treatment risks for diabetes mellitus (DM) in survivors of childhood cancer: A report from the Childhood Cancer Survivor Study (CCSS) and St. Jude Lifetime (SJLIFE) cohorts. (2021) (0)
- Cause-specific mortality in survivors of lymphoplasmacytic lymphoma (LPL) and waldenstrom macroglobulinemia (WM). (2019) (0)
- Correction to: Residential proximity to industrial combustion facilities and risk of non-Hodgkin lymphoma: a case-control study (2021) (0)
- Radiation Doses to the Esophagus from Radiotherapy Treatment for Breast Cancer during 1943-2001 (2011) (0)
- Abstract 1056: Elevated incidence of rare cancers among solid organ transplant recipients (SOTRs) in the United States (2020) (0)
- Congenital Anomalies and Chronic Health Conditions among Childhood Cancer Survivors (2021) (0)
- 087: Anthropometric Indicators and Risk of Lymphoid Malignancies in the Prospective NIH-AARP Diet and Health Study (2005) (0)
- Smoking, variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2), and risk of non-Hodgkin lymphoma: a pooled analysis within the InterLymph consortium (2012) (0)
- Genome-wide association study identifies multiple new loci associated with Ewing sarcoma susceptibility (2018) (0)
- Improvements in life expectancy among childhood cancer survivors: Uneven gains and remaining challenges. (2022) (0)
- Abstract 5736: Household endotoxin levels and risk of non-Hodgkin lymphoma (2010) (0)
- Abstract 1448: Novel specific susceptibility loci identified for pediatric and adult ependymoma in first histology-specific genome-wide association study (2022) (0)
- 273: Participation in Epidemiologic Studies: Survey of Practice (2005) (0)
- lymphoma survival Prognostic significance of host immune gene polymorphisms in follicular (2013) (0)
- Spectrum of pediatric and young adult cancer survivors at risk of developing subsequent sarcomas. (2016) (0)
- Abstract 1318: A genome-wide association study of Waldenström macroglobulinemia/lymphoplasmacytic lymphoma demonstrates association with chromosome 6 (2017) (0)
- Abstract 4490: Molecular characteristics of diffuse large B-cell lymphoma in HIV-positive and HIV-negative patients (2012) (0)
- RE: The Association of Dyslipidemia With Chronic Lymphocytic Leukemia: A Population-Based Study. (2017) (0)
- Title: Genetic Susceptibility to Neurocognitive Impairment Secondary to Childhood Cancer Treatment Working Group: Genetics Psychology Investigators: (2019) (0)
- Shedding light on UVR and Hodgkin lymphoma. (2013) (0)
- Polycyclic aromatic hydrocarbons: determinants of residential carpet dust levels and risk of non-Hodgkin lymphoma (2015) (0)
- Germline Genetic and Treatment-Related Risk Factors for Diabetes Mellitus in Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study and St Jude Lifetime Cohorts. (2022) (0)
This paper list is powered by the following services:
Other Resources About Lindsay Morton
What Schools Are Affiliated With Lindsay Morton?
Lindsay Morton is affiliated with the following schools:
